Scholar Rock Holding Corporation (SRRK) — Stock Score Summary

Scholar Rock Holding Corporation (SRRK) has a MoatMap StockRank of 30/100 based on Quality (21/100), Value (34/100), and Momentum (62/100) factor scores. The current signal is SELL. Scholar Rock is a clinical-stage biopharmaceutical company. It has no commercialized products, high cash burn, and is highly speculative, failing the quality compounder criteria of Terry Smith and Warren Buffett.

Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company focused on discovering and developing novel medicines for serious diseases by targeting the transforming growth factor beta (TGFβ) superfamily. Its proprietary platform and precision approach to modulating protein activation offer a unique competitive advantage in addressing unmet medical needs. The company's innovative drug candidates aim to treat neuromuscular and fibrotic diseases.

Key Financial Metrics

Price$45.58
Market Cap$6.0B
P/E (Forward)-19.13
Price/Book20.03
Return on Equity-138.9%
Return on Invested Capital-106.4%
Debt/Equity74.52
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-172M

Scholar Rock Holding Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Scholar Rock Holding Corporation’s (SRRK) StockRank?
MoatMap’s StockRank for Scholar Rock Holding Corporation (SRRK) is 30/100, with a Sell signal. It is a composite of Quality (21), Value (34), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Scholar Rock Holding Corporation have an economic moat?
Scholar Rock Holding Corporation (SRRK) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Scholar Rock Holding Corporation a buy, hold, or sell?
MoatMap’s current signal for Scholar Rock Holding Corporation (SRRK) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Scholar Rock Holding Corporation in?
Scholar Rock Holding Corporation (SRRK) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSRRK deep dive reportAI ChampionsHow we score stocksSense-check another stock